Gene · 6392
Papers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long Noncoding RNA LOC554202 Predicts a Poor Prognosis and Correlates with Immune Infiltration in Thyroid Cancer. | Comput Math Methods Med | 2022 | 35265169 | PubTator, text mining | PubMed |
| Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer. | PLoS Comput Biol | 2022 | 35263321 | PubTator, text mining | PubMed |
| Anti-aging effects of chlorpropamide depend on mitochondrial complex-II and the production of mitochondrial reactive oxygen species. | Acta Pharm Sin B | 2022 | 35256938 | PubTator, text mining | PubMed |
| Genetic susceptibility to hereditary non-medullary thyroid cancer. | Hered Cancer Clin Pract | 2022 | 35255942 | PubTator, text mining | PubMed |
| Distinct metabolic profiles associated with autism spectrum disorder versus cancer in individuals with germline PTEN mutations. | NPJ Genom Med | 2022 | 35241692 | PubTator, text mining | PubMed |
| Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients. | Orphanet J Rare Dis | 2022 | 35227301 | PubTator, text mining | PubMed |
| A Rare Case of Simultaneous Pheochromocytoma Accompanied with an Ileocecal Neuroendocrine Tumor. | Case Rep Oncol | 2022 | 35221966 | PubTator, text mining | PubMed |
| The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. | Nat Cancer | 2022 | 35221333 | PubTator, text mining | PubMed |
| Giant carotid chemodectoma treated with a combination of surgery and CyberKnife radiotherapy: a case report and review of the literature. | J Med Case Rep | 2022 | 35216640 | PubTator, text mining | PubMed |
| The Role of the Metabolome and Non-Coding RNA on Pheochromocytomas and Paragangliomas: An Update. | Metabolites | 2022 | 35208206 | PubTator, text mining | PubMed |
| Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance. | Cancers (Basel) | 2022 | 35205664 | PubTator, text mining | PubMed |
| The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis. | Genes (Basel) | 2022 | 35205407 | PubTator, text mining | PubMed |
| Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance. | Biomedicines | 2022 | 35203491 | PubTator, text mining | PubMed |
| Mitochondrial Neurodegeneration. | Cells | 2022 | 35203288 | PubTator, text mining | PubMed |
| [177Lu]Lu-DOTA-TATE and [131I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center. | Front Endocrinol (Lausanne) | 2022 | 35197929 | PubTator, text mining | PubMed |
| Research on the Damage of Adrenal Pheochromocytoma to Patients' Cardiovascular Vessels and Its Correlation with Hypertension. | J Oncol | 2022 | 35186079 | PubTator, text mining | PubMed |
| Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib. | NPJ Breast Cancer | 2022 | 35181666 | PubTator, text mining | PubMed |
| Predictive model of pheochromocytoma based on the imaging features of the adrenal tumours. | Sci Rep | 2022 | 35177692 | PubTator, text mining | PubMed |
| Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine. | Endocr Relat Cancer | 2022 | 35171114 | PubTator, text mining | PubMed |
| FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumor. | Genes Chromosomes Cancer | 2022 | 35170141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6392/papers?page=32